ERBB2 and breast cancer: The most upregulated miRNAs in trastuzumab-resistant HER2+ BC patients were miR-1246 and miR-155, which were further validated in the trastuzumab-resistant patients’ samples (n = 32) vs. trastuzumab-sensitive cases (n = 36).